Iberian Healthcare Collaboration: Spain & Portugal Unite for Health Technology Assessments!

The European Federation of Pharmaceutical Industries Associations (EFPIA) warns of Europe’s declining clinical trial opportunities. It stresses the need for the EU clinical trials strategy to tackle these issues. Since 2013, Europe has lost 60,000 trial spots, with trials shifting to the U.S. and...

The FLAURA2 Phase III trial's final analysis confirms that the Tagrisso chemotherapy combo improves overall survival (OS) in untreated patients with EGFR-mutated NSCLC. This combination of osimertinib with pemetrexed and platinum-based chemotherapy outperformed Tagrisso monotherapy. The regimen m...

Innovative approaches to brain health increasingly recognize that patient experience data (PXD)—systematically collected information on patients’ lived experiences of interventions and disease—are crucial for aligning research, development, and regulatory decisions with real-world needs. The refe...